BrightFocus Foundation
Company, NonprofitWikidata
People
Sources: doi.org
Awards made
BrightFocus Foundation: Other, Understanding Natural Protection Against Cognitive Decline: The 100-plus Study, CA2027001, 2026–2027, 1 Aug 2026
Alzheimer's Disease Research: Standard, Longitudinal Myelin Proteome and ATN Biomarker Changes as Drivers of White Matter Hyperintensities in the Jackson Heart Study, A2026004F, 2026–2028, 1 Jul 2026
Macular Degeneration Research: Standard, Probing Choriocapillaris Flow Voids and Reticular Pseudodrusen through Ocular Stress Tests, M2026009N, 2026–2029, 1 Jul 2026
Macular Degeneration Research: Standard, Probing Choriocapillaris Flow Voids and Reticular Pseudodrusen through Ocular Stress Tests, M2026009N, US$450k, 2026–2029, 1 Jul 2026
Alzheimer's Disease Research: Standard, Beyond Pathology: A Spatially Resolved Multi-Omic Atlas of Cognitive Resilience in Extreme Aging, A2026029S, 2026–2029, 1 Jul 2026
University of California-irvine
Alzheimer's Disease Research: Standard, Beyond Pathology: A Spatially Resolved Multi-Omic Atlas of Cognitive Resilience in Extreme Aging, A2026029S, US$299.8k, 2026–2029, 1 Jul 2026
Alzheimer's Disease Research: Standard, Mapping cell state transitions in brain aging to predict rejuvenating therapeutic targets, A2026030S, 2026–2029, 1 Jul 2026
Alzheimer's Disease Research: Standard, Mapping cell state transitions in brain aging to predict rejuvenating therapeutic targets, A2026030S, US$300k, 2026–2029, 1 Jul 2026
Alzheimer's Disease Research: Standard, Visual System Vulnerability In Dementia: From Detection To Determinants, A2026032S, 2026–2029, 1 Jul 2026
Alzheimer's Disease Research: Standard, Visual System Vulnerability In Dementia: From Detection To Determinants, A2026032S, US$291.7k, 2026–2029, 1 Jul 2026
Alzheimer's Disease Research: Standard, Ovarian Macrophages as Drivers of Neuroinflammation and Cognitive Decline in Alzheimer's Disease, A2026024S, 2026–2029, 1 Jul 2026
Oklahoma Medical Research Foundation
Alzheimer's Disease Research: Standard, Ovarian Macrophages as Drivers of Neuroinflammation and Cognitive Decline in Alzheimer's Disease, A2026024S, US$300k, 2026–2029, 1 Jul 2026
Macular Degeneration Research: Standard, Mapping the Molecular-Imaging Interface in Age-Related Macular Degeneration: A Multimodal Approach, M2026010N, 2026–2029, 1 Jul 2026
German Center for Neurodegenerative Diseases
Macular Degeneration Research: Standard, Mapping the Molecular-Imaging Interface in Age-Related Macular Degeneration: A Multimodal Approach, M2026010N, US$450k, 2026–2029, 1 Jul 2026
BrightFocus Foundation: Standard, lifespan perfusion TRAjectories In ageing and Alzheimer's Disease (TRAILAD), CA2026001, 2026–2027, 1 Jan 2026
BrightFocus Foundation: Standard, lifespan perfusion TRAjectories In ageing and Alzheimer's Disease (TRAILAD), CA2026001, US$104.8k, 2026–2027, 1 Jan 2026
Macular Degeneration Research: Standard, Realtime monitoring of the expression of AMD risk genes TLE2 and FRZB in retinal pigment epithelium in vivo, M2025001N, 2025–2028, 1 Jul 2025
Macular Degeneration Research: Standard, Realtime monitoring of the expression of AMD risk genes TLE2 and FRZB in retinal pigment epithelium in vivo, M2025001N, US$409.5k, 2025–2028, 1 Jul 2025
Macular Degeneration Research: Standard, Microglial Regulation of Developing and Restored Cone Visual Circuits, M2025012F, 2025–2027, 1 Jul 2025
Macular Degeneration Research: Standard, Microglial Regulation of Developing and Restored Cone Visual Circuits, M2025012F, US$180.9k, 2025–2027, 1 Jul 2025
Sources: openalex.org
Funded papers
CA2023001, 10 Sept 2026
Sources: api.crossref.org
Named in competing interests
The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV
Fees or honoraria, Grants or research support, 24 Sept 2026
Fees or honoraria, 15 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov